Health
Common blood-thinning drug emerges as potential therapeutic treatment during Covid – Times of India
A common blood-thinning drug — Low Molecular Weight Heparin (LMWH) — has emerged as a potential therapeutic treatment for Covid-19 patients. Doctors said the drug — as a subcutaneous injection — has helped reduce hospitalisation periods, improved recovery ra…
Aug 30, 2020, 03:44PM ISTSource: TOI.inA common blood-thinning drug Low Molecular Weight Heparin (LMWH) has emerged as a potential therapeutic treatment for Covid-19 patients. Doctors said the drug as a subcutaneous injection has helped reduce hospitalisation periods, improved recovery rate and has significantly cut the rate of sudden deaths by over 90%. Encouraged by the outcomes, specialists TOI spoke to said doctors nationwide were now using the drug as a prophylactic (preventive) therapy to …
-
Business23 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News22 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business18 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News21 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses